IN THE HEART OF DATA: Exploring Patient Characteristics in the MY-HF Registry and Improving the Use of Combination Drug Therapy

01 Feb 2024
IN THE HEART OF DATA:
Exploring Patient Characteristics in the MY-HF Registry and
Improving the Use of Combination Drug The
Heart failure (HF) poses a growing health challenge, impacting over 26 million people worldwide. Recently published in ESC Heart Failure, the MY-HF Registry stands as the first Malaysian multicenter, observational, 3-year prospective study of 2,717 Malaysian patients admitted for acute HF (New York Heart Association [NYHA] class II‒IV) from 18 participating hospitals across Malaysia. These hospitals include those under the Ministry of Health and Ministry of Higher Education, the National Heart Institute and a private cardiac hospital within the country. The MY-HF Registry, initiated by the National Heart Association of Malaysia, sheds light on the baseline characteristics, treatment patterns and outcomes of patients during their index hospitalisation for HF.
Sponsored as an educational program by Novartis Corporation (Malaysia) Sdn Bhd

Resources

MY-NOV-336

MY-NOV-336

MY-NOV-336

MY-NOV-336